Tacrolimus

interleukin 2 ; Homo sapiens







135 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 11805719 Protein ubiquitin is an immunophilin. 2002 Feb 1
52 11987039 [Topical Fk506 in inflammatory corneal and conjunctival diseases. A pilot study]. 2002 Mar 1
53 12091117 FK506 in the maturation of dendritic cells. 2002 Jul 4
54 12372041 Daclizumab induction/tacrolimus sparing: a randomized prospective trial in renal transplantation. 2002 1
55 14561179 Emerging treatments for autoimmune hepatitis. 2002 Dec 1
56 11176043 Topical tacrolimus. 2001 2
57 11407316 Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids). 2001 Jun 1
58 11477316 Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells. 2001 Aug 5
59 11516757 Functional quantification of cyclosporine A and FK506 in human whole blood by flow cytometry, using the green fluorescent protein as an interleukin-2 reporter gene. 2001 Oct 1 1
60 11714196 Inhibition of cytokine production and cytokine-stimulated T-cell activation by FK506 (tacrolimus)1. 2001 1
61 10878284 Immunosuppressive drugs: the first 50 years and a glance forward. 2000 May 2
62 10887335 Control of IL-5 production by human helper T cells as a treatment for eosinophilic inflammation: comparison of in vitro and in vivo effects between selective and nonselective cytokine synthesis inhibitors. 2000 Jul 1
63 10972232 Mechanism of the combination immunosuppressive effects of rapamycin with either cyclosporine or tacrolimus. 2000 Aug 27 1
64 11053632 Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses. 2000 Sep 1
65 11258483 Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation. 2000 Nov 2
66 18034554 Long term management of liver transplant rejection in children. 2000 Jul 2
67 10515221 Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients. 1999 Oct 5
68 10555752 The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines. 1999 Nov 1
69 9565564 Polyomavirus middle T antigen as a probe for T cell antigen receptor-coupled signaling pathways. 1998 May 8 1
70 9620363 Mapping interleukin enhancer binding factor 3 gene (ILF3) to human chromosome 19 (19q11-qter and 19p11-p13.1) by polymerase chain reaction amplification of human-rodent somatic cell hybrid DNA templates. 1998 May 4
71 9667420 Tacrolimus-induced apoptosis and its prevention by interleukins in mitogen-activated human peripheral-blood mononuclear cells. 1998 Mar 2
72 9878113 Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL-2 and TNF-alpha by activated human T cells. 1998 Dec 15 1
73 9032415 Detection and quantification of cyclosporine in body fluids using an interleukin-2 reporter-gene assay. 1997 Feb 14 1
74 9045922 T cell sensitivity to HLA class I-mediated apoptosis is dependent on interleukin-2 and interleukin-4. 1997 Feb 1
75 9103428 IL-2-induced IL-5 synthesis, but not proliferation, of human CD4+ T cells is suppressed by FK506. 1997 Apr 15 4
76 9112351 A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. 1997 Apr 15 2
77 9182928 In vivo mechanisms for the inhibition of T lymphocyte activation by long-term therapy with tacrolimus (FK-506): experience in patients with Behçet's disease. 1997 Jun 1
78 9190906 Autocrine and paracrine regulation of human T cell IL-10 production. 1997 Jun 15 1
79 9407429 Impact of new immunosuppressive agents on late graft outcome. 1997 Dec 1
80 8669110 RO 31-8220, a novel protein kinase C inhibitor, inhibits early and late T cell activation events. 1996 Jun 15 1
81 8717522 Immunopharmacology of rapamycin. 1996 1
82 8786538 Mixed agonist/antagonist activity of an FK-506-related immunosuppressant: biological and biochemical characterization. 1996 Mar 1
83 8906804 Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis. 1996 Nov 15 1
84 8939643 Transcription-modulating drugs: mechanism and selectivity. 1996 Dec 1
85 8974006 Mapping interleukin enhancer binding factor 2 gene (ILF2) to human chromosome 1 (1q11-qter and 1p11-p12) by polymerase chain reaction amplification of human-rodent somatic cell hybrid DNA templates. 1996 Dec 2
86 7543780 Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2. 1995 Apr 1
87 7552894 Tacrolimus: a new immunosuppressive agent. 1995 Jul 15 1
88 7759865 Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes. 1995 Jun 15 2
89 8557519 Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation. 1995 Sep 1
90 8744655 2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506). 1995 1
91 8846199 Cytokine production by phytohemagglutinin-stimulated human blood cells: effects of corticosteroids, T cell immunosuppressants and phosphodiesterase IV inhibitors. 1995 Sep 1
92 9346613 FK506 in liver transplantation for chronic hepatitis B: in vitro studies on lymphocyte activation and virus replication. 1995 Nov 1
93 7507994 Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes. 1994 Jan 2
94 7517981 Immunosuppressive effects of azelastine hydrochloride on contact hypersensitivity and T-cell proliferative response: a comparative study with FK-506. 1994 Jul 5
95 7518678 Interaction of tacrolimus(FK506) and its metabolites with FKBP and calcineurin. 1994 Jul 15 2
96 7522130 FK506 and cyclosporin A each inhibit antigen-specific signaling in the T cell line 171 in the absence of a calcium signal. 1994 Oct 1 2
97 7522636 Properties of transcription factors regulating interleukin-2 gene transcription through the NFAT binding site in untreated or drug-treated naive and memory T-helper cells. 1994 Oct 15 1
98 7529381 In-vitro effects of cyclosporin A, FK506, 6-mercaptopurine, and prednisolone on lymphokine-activated killer cells. 1994 1
99 7923750 Cyclosporine: mechanisms of action and toxicity. 1994 Jul-Aug 1
100 7974924 [New immunosuppressive therapies in kidney transplantation]. 1994 Sep 1